European science conversations
by the community, for the community
All aspects of doing research with integrity and honesty are being discussed in this section
Academic and research integrity cannot be a side project or an afterthought. Integrity and ethics must be central to everything we do and every decision we make. We must work to ensure that we are putting integrity at the forefront of our mission and operations. To achieve objectives mentioned it requests to respect the framework of integrity policies, processes and procedures at all institutional levels. Integrity policies, processes and procedures are an inseparable and significant part of the whole set of functions/activities within an institution that work together for the aim of the institution. Read more [...]
On the EU level there are the anti-plagiarism policies not defined in the higher education sector, although plagiarism-related projects are being supported. Read more [...]
The term ‘value’ is at the centre of an increasingly explicit debate in the fields of health and healthcare policy. ‘Value’ is understood in many different ways and diverging interests are being mobilised. How are values in biomedical innovation being expressed, represented, materialised and aligned or contested in different areas of biomedicine? How do values embedded in regulation, public health, economic policies, healthcare provision, technology assessment, producers' strategies, and patient organisation movements shape biomedical innovations? At an ESOF discussion in Toulouse multidisciplinary perspectives on value between panel members and public participants will be explored and possible pathways to common solutions identified that promote socially acceptable biomedical innovation in the European context. Read more [...]
The scandal of regenerative medicine surgeon Paolo Macchiarini and his deadly plastic tracheas made world news. Yet this human abuse, which started at the Karolinska Institutet in Sweden, was just a part of a much bigger horror story. The suffering and deaths of other trachea transplant patients of Macchiarini and his collaborators, those who received a decellurised cadaveric trachea, is much less known. I focused my reporting on it, bringing back to memory all those dead patients which the hospitals in London, Florence and Barcelona pretend never existed. Presently, 62 patients were scheduled to be treated with decellurised cadaveric trachea in two phase 1 clinical trials in UK and one EU-funded phase 2 clinical trial, all led by former Macchiarini partner, UCL laryngologist Martin Birchall. But now, all 3 clinical trials are not going anywhere. Read more [...]
EuroScientist journal 
![The Critical Ethos of the Open Society: A Reply to Esfeld [1]](https://i0.wp.com/www.euroscientist.com/wp-content/uploads/2021/11/pedestrians-g56a3cedca_1920.jpg?resize=672%2C372&ssl=1)
